Skip to main content
. 2019 Jul 5;11(7):1534. doi: 10.3390/nu11071534

Table 4.

Effects and differences between sexes, of maternal hydroxytyrosol supplementation on the fatty acid profile of the fetal longissimus dorsi muscle. Mean values (±SEM) of neutral lipids in female (F) and male (M) fetuses of the treated (HTX) and the control group (C).

HTX C p-Value
Fatty Acids (g/100 g Total Fatty Acids) Mean Female Male Mean Female Male HTX vs. C Global Same Sex (HTX vs. C) Same Experimental Group (F vs. M)
HTX vs. C Females HTX vs. C Males F vs. M within HTX Group F vs. M within C Group
C14:0 3.30 ± 0.05 3.25 ± 0.05 3.29 ± 0.05 3.31 ± 0.09 3.25 ± 0.07 3.24 ± 0.06 0.436 0.65 0.521 0.841 0.923
C16:0 29.89 ± 0.20 29.85 ± 0.21 29.85 ± 0.25 29.93 ± 0.34 29.79 ± 0.3 29.93 ± 0.31 0.905 0.875 0.99 0.841 0.748
C16:1n-9 2.93 ± 0.13 2.60 ± 0.04 2.91 ± 0.16 2.96 ± 0.24 2.66 ± 0.04 2.52 ± 0.06 0.012 0.118 0.056 0.874 0.05
C16:1n-7 6.54 ± 0.15 6.84 ± 0.13 6.55 ± 0.18 6.52 ± 0.27 6.85 ± 0.18 6.83 ± 0.18 0.125 0.248 0.352 0.918 0.921
C17:0 1.34 ± 0.04 1.37 ± 0.03 1.33 ± 0.05 1.37 ± 0.05 1.38 ± 0.04 1.35 ± 0.04 0.608 0.414 0.795 0.618 0.572
C17:1 1.20 ± 0.04 1.15 ± 0.04 1.22 ± 0.06 1.16 ± 0.06 1.12 ± 0.06 1.20 ± 0.05 0.482 0.424 0.658 0.476 0.37
C18:0 11.13 ± 0.12 12.38 ± 0.14 11.00 ± 0.13 11.32 ± 0.22 12.21 ± 0.16 12.58 ± 0.25 0,000 0,000 0.001 0.196 0.202
C18:1n-9 22.62 ± 0.15 23.06 ± 0.15 22.89 ± 0.20 22.25 ± 0.23 22.98 ± 0.21 23.16 ± 0.23 0.048 0.752 0.009 0.04 0.574
C18:1n-7 7.22 ± 0.09 7.43 ± 0.06 7.11 ± 0.11 7.38 ± 0.14 7.35 ± 0.08 7.52 ± 0.09 0.056 0.081 0.38 0.14 0.13
C18:2n-6 4.50 ± 0.11 3.78 ± 0.11 4.60 ± 0.15 4.35 ± 0.17 3.75 ± 0.18 3.82 ± 0.12 0,000 0.001 0.012 0.295 0.764
C18:3n-3 0.32 ± 0.01 0.31 ± 0.01 0.32 ± 0.01 0.32 ± 0.02 0.30 ± 0.01 0.32 ± 0.01 0.405 0.302 0.984 0.813 0.378
C20:1n-9 0.46 ± 0.01 0.43 ± 0.01 0.45 ± 0.01 0.47 ± 0.01 0.43 ± 0.01 0.42 ± 0.02 0.035 0.34 0.05 0.176 0.677
C20:3n-6 0.58 ± 0.01 0.49 ± 0.01 0.57 ± 0.02 0.58 ± 0.02 0.51 ± 0.02 0.47 ± 0.02 0,000 0.04 0,000 0.866 0.163
C20:4n-6 5.17 ± 0.17 4.64 ± 0.23 5.12 ± 0.21 5.24 ± 0.29 4.85 ± 0.35 4.38 ± 0.29 0.081 0.529 0.046 0.742 0.316
C20:5n-3 0.19 ± 0.01 0.19 ± 0.01 0.19 ± 0.01 0.20 ± 0.01 0.20 ± 0.01 0.18 ± 0.01 0.917 0.275 0.172 0.26 0.188
C22:4n-6 1.27 ± 0.03 1.03 ± 0.05 1.26 ± 0.03 1.28 ± 0.04 1.07 ± 0.07 0.97 ± 0.05 0,000 0.025 0,000 0.678 0.238
C22:5n-3 0.45 ± 0.01 0.36 ± 0.02 0.46 ± 0.01 0.45 ± 0.02 0.40 ± 0.03 0.32 ± 0.03 0.001 0.126 0.001 0.858 0.114
C22:6n-3 0.89 ± 0.02 0.83 ± 0.04 0.88 ± 0.03 0.91 ± 0.04 0.87 ± 0.05 0.79 ± 0.04 0.195 0.879 0.059 0.524 0.249
SFA 45.67 ± 0.20 46.84 ± 0.27 45.47 ± 0.24 45.93 ± 0.32 46.64 ± 0.38 47.10 ± 0.39 0.001 0.015 0.031 0.252 0.399
MUFA 40.97 ± 0.21 41.51 ± 0.24 41.13 ± 0.25 40.74 ± 0.34 41.4 ± 0.36 41.65 ± 0.30 0.093 0.555 0.052 0.35 0.606
PUFA 13.37 ± 0.28 11.64 ± 0.42 13.39 ± 0.37 13.33 ± 0.42 11.96 ± 0.64 11.25 ± 0.53 0.002 0.068 0.005 0.911 0.406
UI 0.85 ± 0.01 0.80 ± 0.02 0.85 ± 0.01 0.85 ± 0.02 0.82 ± 0.02 0.79 ± 0.02 0.009 0.185 0.014 0.942 0.316
PUFAn-3 1.86 ± 0.03 1.70 ± 0.06 1.84 ± 0.04 1.88 ± 0.05 1.77 ± 0.10 1.61 ± 0.08 0.042 0.523 0.011 0.61 0.213
PUFAn-6 11.51 ± 0.25 9.95 ± 0.36 11.55 ± 0.33 11.45 ± 0.38 10.19 ± 0.55 9.64 ± 0.45 0.001 0.047 0.005 0.845 0.456
Σn-6/Σn-3 6.20 ± 0.08 5.90 ± 0.1 6.27 ± 0.10 6.10 ± 0.12 5.78 ± 0.14 6.05 ± 0.14 0.025 0.009 0.795 0.257 0.201
C18:1/C18:0 2.70 ± 0.04 2.48 ± 0.03 2.74 ± 0.04 2.64 ± 0.06 2.49 ± 0.03 2.46 ± 0.05 0,000 0,000 0.017 0.16 0.515
MUFA/SFA 0.9 ± 0.01 0.89 ± 0.01 0.91 ± 0.01 0.89 ± 0.01 0.89 ± 0.01 0.89 ± 0.01 0.207 0.114 0.862 0.162 0.797

FA (g/100 g Total FA) = Fatty Acids (g/100 g Total Fatty Acids); SFA = Saturated fatty acids. Includes: C14:0, C16:0, C17:0 and C18:0; MUFA = Monounsaturated fatty acids. Includes: C16:1n-9, C16:1n-7, C17:1, C18:1n-9, C18:1n-7, C20:1n-9; PUFA = Polyunsaturated fatty acids. Includes: C18:2n-6, C18:3n-3, C20:3n-9, C20:3n-6, C20:4n-6, C20:5n-3, C22:4n-6, C22:5n-6, C22:5n-3 and C22:6n-3; UI = Unsaturation index; Includes: C18:2n-6, C20:4n-6 and C22:4n-6; Includes: C18:3n-3, C20:5n-3 and C22:6n-3.